| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| FON_NAZ - Bandi Altre Fondazioni |
Evidence-based approach to treat hyperexcitability in Rett syndrome though splicing modulation
|
|
Ongoing | 2021 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional relevance of different tetraspanin-like MS4A members for FcRs antitumor activities in target therapies (2° anno)
|
|
Closed | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Targeting allo-reactive Natural Killer cell immune reconstitution in hematologic tumors after bone marrow transplant (4° anno)
|
|
Closed | 2022 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Enhanced Delivery Ecosystem for Neurosurgery in 2020
|
|
Closed | 2015 |
| H20_RIA - Horizon 2020_Research & Innovation Action/Innovation Action |
Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease (LifeTime)
|
|
Closed | 2019 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
| INTLI - Finanziamenti internazionali |
Dissecting the molecular mechanism linking GCase-dependent lysosomal impairment with Parkinson’s disease
|
|
Closed | 2022 |
| INTLI - Finanziamenti internazionali |
Branched chain amino acids-induced persistent metabolic shift towards oxidative phosphorylation in immune and neural cells: a potential new therapy for Progressive Multiple Sclerosis
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
Ampakine-mediated modulation of neuronal activity for the treatment of Rett syndrome: proposal for a preclinical study
|
|
Closed | 2021 |
| INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
